Suchergebnisse - "Motoi, Noriko"

PubPharm (9)

1

A Grading System for Invasive Pulmonary Adenocarcinoma : A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2020

von Moreira, A. | Ocampo, P. | Xia, Y. | +41

2

Long-read sequencing for non-small-cell lung cancer genomes

enthalten in: Genome research | 2020

von Sakamoto, Y. | Xu, L. | Seki, M. | +12

3

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2020

von Travis, W. | Dacic, S. | Wistuba, I. | +40

CommentIn: J Thorac Oncol. 2021 Jan;16(1):e7-e9. - PMID 33384061

4

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease

enthalten in: The American journal of surgical pathology | 2014

von Kadota, K. | Villena-Vargas, J. | Yoshizawa, A. | +6

5

Identification of DOK genes as lung tumor suppressors

enthalten in: Nature genetics | 2010

von Berger, A. | Niki, M. | Morotti, A. | +11

6

Gene expression-based survival prediction in lung adenocarcinoma : a multi-site, blinded validation study

enthalten in: Nature medicine | 2008

von Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma | Shedden, K. | Taylor, J. | +38

CommentIn: Nat Med. 2008 Aug;14(8):812-3. - PMID 18685594

7

Lung adenocarcinoma : modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis

enthalten in: The American journal of surgical pathology | 2008

von Motoi, N. | Szoke, J. | Riely, G. | +5

8

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2007

von Bean, J. | Brennan, C. | Shih, J. | +20

9

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

enthalten in: The Journal of clinical investigation | 2007

von Gao, S. | Mark, K. | Leslie, K. | +8

CommentIn: J Clin Invest. 2007 Dec;117(12):3660-3. - PMID 18060028

1
[1]